Modifications of nuclear architecture and chromatin organization in ataxia telangiectasia cells are coupled to changes of gene transcription

Journal of Cellular Biochemistry

Volumn 99, Issue 4, 2006, Pages 1148-1164

  Grattarola, Myriam ^a   Borghi, Cristina ^a   Emionite, Laura ^a   Lulli, Patrizia ^b   Chessa, Luciana ^b   Vergani, Laura ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Ataxia telangiectasia; Chromatin structure; Gene transcription; Nuclear architecture

Indexed keywords

ATM PROTEIN; DNA; METALLOTHIONEIN; PROTEIN P21; PROTEIN P53;

ACETYLATION; ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; CELL CYCLE; CELL NUCLEUS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN CONDENSATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CYTOARCHITECTURE; DIFFERENTIAL SCANNING CALORIMETRY; DNA DAMAGE; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; NUCLEOSOME; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; THREE DIMENSIONAL IMAGING; UPREGULATION;

ATAXIA TELANGIECTASIA;

EID: 33750537684     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20895     Document Type: Article

References (90)

1. Abraham RT. 2001. Cell-cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196.
2. Agard DA. 1984. Optical sectioning microscopy: Cellular architecture in three dimensions. Annu Rev Biophys Bioeng 13:191-219.
3. Agard DA, Hiraoka Y, Shaw P, Sedat JW. 1989. Fluorescence microscopy in three dimensions. Meth Cell Biol 30:353-377.
4. Allegra P, Sterner R, Clayton DF, Allfrey VG. 1987. Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequences. J Mol Biol 196:379-388.
5. Allera C, Lazzarini G, Patrone E, Alberti I, Barboro P, Sanna P, Merchiori A, Parodi S, Balbi C. 1997. The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem 272:10817-10822.
6. Allfrey VG, Chen TA. 1991. Nucleosomes of transcriptionally active chromatin: Isolation of template-active nucleosomes by affinity chromatography. Meth Cell Biol 55:315-333.
7. Bakka A, Endresen L, Johnsen AB, Edminson PD, Rugstad HK. 1981. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 61:215-226.
8. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
9. Balbi C, Abelmoschi ML, Gogioso L, Parodi S, Barboro P, Cavazza B, Patrone E. 1989. Structural domains and conformational changes in nuclear chromatin: A quantitative thermodynamic approach by differential scanning calorimetry. Biochemistry 28:3220-3227.
10. Bartels PH. 1979. Numerical evaluation of cytological data. Description of profiles. Anal Quant Cytol Histol 1:20-28.
11. Beattie JH, Owen HL, Wallace SM, Arthur JR, Kwun IS, Hawksworth GM, Wallace HM. 2005. Metallothionein overexpression and resistance to toxic stress. Toxicol Lett 157:69-78.
12. Belmont AS, Bruce K. 1994. Visualization of G1 chromosomes: A folded, twisted, supercoiled chromonema model of interphas;e chromatid structure. J Cell Biol 127:287-302.
13. Belmont AS, Kendall FM, Nicolini C. 1980. Coupling of nuclear morphometry to cell geometry and growth in human fibroblasts. Cell Biophys 2:165-175.
14. Belmont A, Kendall FM, Nicolini C. 1984. Three-dimensional intranuclear DNA organization in situ: Three states of condensation and their redistribution as a function of nuclear size near the G1-S border in HeLa S-3 cells. J Cell Sci 65:123-138.
15. Belmont A, Dietzel S, Nye A, Strukov Y, Tumbar T. 1999. Large scale chromatin structure and function. Curr Opin Cell Biol 11:307-311.
16. Bianchi A, Becuwe P, Collet P, Keller JM, Domenjoud L, Dauca M. 2002. Clofibric acid downregulation of metallothionein IIA in HepG2 human hepatoma cells. Biochem Pharmacol 63:237-245.
17. Boulaire J, Fotedar A, Fotedar R. 2000. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol Biol 48:190-202.
18. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
19. Bubulya PA, Spector DL. 2004. "On the move"ments of nuclear components in living cells. Exp Cell Res 296:4-11.
20. Chessa L, Petrinelli P, Antonelli A, Fiorilli M, Elli R, Marcucci L, Federico A, Gandini E. 1992. Heterogeneity in ataxia-telangiectasia: Classical phenotype associated with intermediate cellular radiosensitivity. Am J Med Genet 42:741-746.
21. Chessa L, Lisa A, Fiorani O, Zei G. 1994. Ataxia telangiectasia in Italy: Genetic analysis. Int J Rad Biol 66:S31-S33.
22. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
23. Concannon P, Gatti RA. 1997. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 10:100-107.
24. Cosma MP, Tanaka T, Nasmyth K. 1999. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 97:299-311.
25. Cremer T, Cremer C. 2001. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nature Rev Gen 2:292-301.
26. Cremer M, Kupper K, Wagler B, Wizelman L, Von Hase J, Weiland Y, et al. 2003. Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei. J Cell Biol 162:809-820.
27. Djuzenova CS, Flentje M. 2001. Light scatter and DNA accessibility to propidium iodide of ataxia telangiectasia and fanconi anemia cells. Biochem Biophys Res Commun 286:365-371.
28. Ehrenhofer-Murray AE. 2004. Chromatin dynamics at DNA replication, transcription and repair. Eur J Biochem 271:2335-2349.
29. Gatei M, Shkedy D, Khanna KK, Uziel T, Shiloh Y, Pandita TK, Lavin MF, Rotman G. 2001. Ataxia-telangiectasia: Chronic activation of damage-responsive functions is reduced by α-lipoic acid. Oncogene 20:289-294.
30. Gately DP, Kittle JC, Chan GK, Yen TJ. 1998. Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity. Mol Biol Cell 9:2361-2374.
31. Gavazzo P, Vergani L, Mascetti GC, Nicolini C. 1997. Effects of histone acetylation on chromatin structure. J Cell Biochem 64:466-475.
32. Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev 12:2973-2983.
33. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NG, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y, Bar-Shira A. 1996. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5:433-439.
34. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, Gatti RA, Jorgensen TJ, Shiloh Y, Bar-Shira A. 1998. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 62:551-561.
35. Goodarzi AA, Lees-Miller SP. 2004. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. DNA Repair 3:753-767.
36. Grattarola M, Spaggiari S, Chessa L, Savio C, Nicolini C, Vergani L. 2003. A structural characterization of in situ chromatin on cell-lines isolated from patients affected by ataxia telangiectasia. Int J Biol Macromol 33:23-29.
37. Guo CY, Wang Y, Brautigan DL, Lamer JM. 1999. Histone H1 dephosphorylation is mediated through a radiation-induced signal transduction pathway dependent on ATM. J Biol Chem 26:18715-18720.
38. Gupta A, Sharma GG, Young CS, Agarwal M, Smith ER, Paull TT, Lucchesi JC, Khanna KK, Ludwig T, Pandita TK. 2005. Involvement of human MOF in ATM function. Mol Cell Biol 25:5292-5305.
39. Haussinger D. 1996. The role of cellular hydration in the regulation of cell function. Biochem J 31:697-710.
40. Hiraoka Y, Sedat JW, Agard DA. 1987. The use of a charge-coupled device for quantitative optical microscopy of biological structures. Science 238:36-41.
41. Hittelman WN, Pandita TK. 1994. Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia. Int J Radiat Biol 66:8109-8113.
42. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 7:587-597.
43. Ko LJ, Prives C. 1996. p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
44. Koundrioukoff S, Polo S, Almouzni G. 2004. Interplay between chromatin and cell cycle checkpoints in the context of ATR/ATM-dependent checkpoints. DNA Repair 3:969-978.
45. Kurz EU, Lees-Miller SP. 2004. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair 3:889-900.
46. Lachner M, O'Sullivan RJ, Jenuwein T. 2003. An epigenetic road map for histone lysine methylation. J Cell Sci 116:2117-2124.
47. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
48. Lavin MF, Scott S, Gueven N, Kozlov S, Peng C, Chen P. 2004. Functional consequences of sequence alterations in the ATM gene. DNA Repair 3:1197-1205.
49. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB. 1998. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95:10146-10151.
50. Marchi B, Burlando B, Panfili I, Pondero F, Viarengo A, Gallo G, 2005. Heavy metal interference with growth hormone signalling in trout hepatoma cells RTH-149. Biometals 18:179-190.
51. Marmorstein R. 2001. Structure and function of histone acetyltransferases. Cell Mol Life Sci 58:693-703.
52. Marshall WF. 2003. Gene expression and nuclear architecture during development and differentiation. Mech Dev 120:1217-1230.
53. Mascetti G, Vergani L, Diaspro A, Carrara S, Radicchi G, Nicolini C. 1996. Effect of fixatives on calf thymocytes chromatin as analyzed by 3D high-resolution fluorescence microscopy. Cytometry 23:110-119.
54. Mascetti G, Carrara S, Vergani L. 2001. The relationship between fiber folding and dye uptake for in situ chromatin stained with a DNA-selective dye. Cytometry 44:113-119.
55. Nicolini C, Vergani L, Diaspro A, Scelza P. 1988a. Native chromatin and damage induced by nuclease. Biochem Biophys Res Commun 155:1396-1403.
56. Nicolini C, Diaspro A, Vergani L, Cittadini G. 1988b. In situ thermodynamics characterization of chromatin and other macromolecules during the cell cycle. Int J Biol Macrom 10:137-144.
57. Nigg EA, Blangy A, Lane HA. 1996. Dynamic changes in nuclear architecture during mitosis: On the role of protein phosphorylation in spindle assembly and chromosome segregation. Exp Cell Res 22:174-180.
58. Nilsson JA, Cleveland JL. 2003. Myc pathways provoking cell suicide and cancer. Oncogene 22:9007-9021.
59. North S, Hainaut P. 2000. p53 and cell-cycle control: A finger in every pie. Pathol Biol 48:255-270.
60. Nye AC, Rajendran RR, Stenoien DL, Mancini MA, Katzenellenbogen BS, Belmont AS. 2002. Alteration of large-scale chromatin structure by estrogen receptor. Mol Cell Biol 22:3437-3449.
61. Polach KJ, Widom J. 1995. Mechanism of protein access to specific DNA sequences in chromatin: A dynamic equilibrium model for gene regulation. J Mol Biol 254:130-149.
62. Rich T, Allen RL, Wyllie AH. 2000. Defying death after DNA damage. Nature 407:777-783.
63. Rotman G, Shiloh Y. 1997. The ATM gene and protein: Possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. Cancer Surv 29:285-304.
64. Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., Misener S, editors. Bioinformatics methods and protocols: Methods in molecular biology. Totowa, NJ: Humana Press, pp 365-386 (Code available at http://www-genome. wi.mit.edu/genome_software/ other/primer3.html
65. Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, Wegner RD, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthaler U, Sennefelder H, Brohm M, Weber BH, Schindler D. 1999. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8:69-79.
66. Satoh M, Cherian MG, Imura N, Shimizu H. 1994. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 54:5255-5257.
67. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Sankhavaram RP, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995a. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
68. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. 1995b. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032.
69. Scherthan H, Jerratsch M, Dhar S, Wang YA, Goff SP, Pandita TK. 2000. Meiotic telomere distribution and Sertoli cell nuclear architecture are altered in Atm- and Atm-p53-deficient mice. Mol Cell Biol 20:7773-7783.
70. Schonherr E, Levkau B, Schaefer L, Kresse H, Walsh K. 2001. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in upregulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 276:40687-40692.
71. Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4:131-136.
72. Shiloh Y. 2003. ATM and related protein kinases: Safe-guarding genome integrity. Nature Rew Cancer 3:155-168.
73. Shiloh Y, Kastan MB. 2001. ATM: Genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 83:209-254.
74. Smilenov LB, Dhar S, Pandita TK. 1999. Altered telomere nuclear matrix interactions and nucleosomal periodicity in ataxia telangiectasia cells before and after ionizing radiation treatment. Mol Cell Biol 19:6963-6971.
75. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Pockwinse SH, McNeil S. 1999. Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions. FASEB J 13:157-166.
76. Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ, Taylor AM. 2001. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T → G mutations, showing a less severe phenotype. J Biol Chem 276:30133-30141.
77. Touchette NA, Cole RD. 1985. Differential scanning calorimetry of nuclei reveals the loss of major structural features in chromatin by brief nuclease treatment. Proc Natl Acad Sci USA 82:2642-2645.
78. van Gent DC, Hoeijmakers JH, Kanaar R. 2001. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2:196-206.
79. Vergani L, Gavazzo P, Mascetti G, Nicolini C. 1994. Ethidium bromide intercalation and chromatin structure: A spectropolarimetric analysis. Biochemistry 33:6578-6585.
80. Vergani L, Mascetti G, Nicolini C. 1998. Effects of polyamines on higher-order folding of in situ chromatin. Mol Biol Rep 25:237-244.
81. Vergani L, Fugazza G, Chessa L, Nicolini C. 1999. Changes of chromatin condensation in one patient with ataxia telangiectasia disorder: A structural study. J Cell Biochem 75:578-586.
82. Vergani L, Grattarola M, Nicolini C. 2004. Modifications of chromatin structure and gene expression following induced alterations of cellular shape. Int J Biochem Cell Biol 36:1447-1461.
83. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799.
84. Walker J, Chen TA, Sterner R, Berger M, Winston F, Allfrey VG. 1990. Affinity chromatography of mammalian and yeast nucleosomes. Two modes of binding of transcriptionally active mammalian nucleosomes to organomercurial-agarose columns, and contrasting behavior of the active nucleosomes of yeast. J Biol Chem 265:5736-5746.
85. Weizman N, Shiloh Y, Barzilai A. 2003. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains. J Biol Chem 278:6741-6747.
86. Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P. 1997. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 16:397-401.
87. Workman JL, Kingston RE. 1998. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 67:545-579.
88. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 10:2411-2422.
89. Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D. 1998. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Mol Cell Biol 18:4385-4390.
90. Zink D, Fischer AH, Nickerson JA. 2004. Nuclear structure in cancer cells. Nat Rev Cancer 4:677-687.